{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:17:21Z","timestamp":1788945441449,"version":"build-2803163510"},"reference-count":62,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Hematologists have a significant role in the diagnosis and management of light-chain amyloidosis and are frequently involved in the diagnosis of transthyretin and other more rare types of amyloidosis. Recent advances in diagnostic techniques and therapies are dramatically improving patient prognosis. Radionuclide imaging methods are emerging as a highly specific and noninvasive way to diagnose, quantify, and monitor organ involvement representing a major advance in amyloidosis management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024026386","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:56:36Z","timestamp":1752612996000},"page":"1157-1162","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Visualizing amyloidosis: the role of radionuclide imaging in systemic amyloidosis"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-1000","authenticated-orcid":false,"given":"Nirija","family":"Ranjit Anderson","sequence":"first","affiliation":[{"name":"1Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia"},{"name":"2Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-1185","authenticated-orcid":false,"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[{"name":"3Amyloidosis Program, Cardiovascular Division, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-1198","authenticated-orcid":false,"given":"Peter","family":"Mollee","sequence":"additional","affiliation":[{"name":"1Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia"},{"name":"2Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2025090411220340000_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J Intern Med"},{"issue":"1","key":"2025090411220340000_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"key":"2025090411220340000_bib3","doi-asserted-by":"crossref","first-page":"100720","DOI":"10.1016\/j.blre.2020.100720","article-title":"The diagnostic challenges of cardiac amyloidosis: a practical approach to the two main types","volume":"45","author":"Varga","year":"2021","journal-title":"Blood Rev"},{"issue":"24","key":"2025090411220340000_bib4","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry\u2013based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2025090411220340000_bib5","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","article-title":"Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples","volume":"95","author":"Dasari","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2025090411220340000_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12014-016-9133-x","article-title":"Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry","volume":"13","author":"Mollee","year":"2016","journal-title":"Clin Proteomics"},{"issue":"3","key":"2025090411220340000_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cjp2.126","article-title":"The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis","volume":"5","author":"Rezk","year":"2019","journal-title":"J Pathol Clin Res"},{"issue":"4","key":"2025090411220340000_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000508022","article-title":"Confirming the diagnosis of amyloidosis","volume":"143","author":"Wisniowski","year":"2020","journal-title":"Acta Haematol"},{"issue":"6","key":"2025090411220340000_bib9","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"2025090411220340000_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00168873","article-title":"Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis","volume":"20","author":"Sa\u00efle","year":"1993","journal-title":"Eur J Nucl Med"},{"issue":"8","key":"2025090411220340000_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"2025090411220340000_bib12","doi-asserted-by":"crossref","first-page":"355.e15","DOI":"10.1016\/j.amjmed.2005.08.043","article-title":"Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis","volume":"119","author":"Hazenberg","year":"2006","journal-title":"Am J Med"},{"issue":"6","key":"2025090411220340000_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00041552-200211000-00013","article-title":"Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis","volume":"11","author":"Hawkins","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"2025090411220340000_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/13506129.2012.717993","article-title":"Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis","volume":"19","author":"Noordzij","year":"2012","journal-title":"Amyloid"},{"issue":"2","key":"2025090411220340000_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"2025090411220340000_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11886-021-01564-6","article-title":"Multimodality imaging in cardiac amyloidosis","volume":"23","author":"Giblin","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"24","key":"2025090411220340000_bib17","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"2025090411220340000_bib18","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2025090411220340000_bib19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2025090411220340000_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"21","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"issue":"11","key":"2025090411220340000_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"2025090411220340000_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41375-020-0802-4","article-title":"Systemic amyloidosis: moving into the spotlight","volume":"34","author":"Cohen","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"2025090411220340000_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","volume":"22","author":"Quarta","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"2025090411220340000_bib24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using 124I-evuzamitide (124I-P5+14) versus 18F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"22","key":"2025090411220340000_bib25","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2025090411220340000_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13506129.2018.1436048","article-title":"Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)","volume":"25","author":"Phull","year":"2018","journal-title":"Amyloid"},{"issue":"11","key":"2025090411220340000_bib27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.hlc.2016.12.017","article-title":"The utility of 99mTc-DPD scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience","volume":"26","author":"Moore","year":"2017","journal-title":"Heart Lung Circ"},{"issue":"24","key":"2025090411220340000_bib28","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/eurheartj\/ehad281","article-title":"Expanding indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy","volume":"44","author":"Dorbala","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"2025090411220340000_bib29","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","article-title":"Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate: a test in evolution","volume":"14","author":"Poterucha","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2025090411220340000_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1309\/AJCP8VOT5TVLAQBQ","article-title":"Borderline high serum free light chain kappa\/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory states","volume":"132","author":"Marshall","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"2025090411220340000_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1515\/cclm-2015-0799","article-title":"Comparison of Freelite and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis","volume":"54","author":"Kennard","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"2025090411220340000_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41408-022-00732-3","article-title":"Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study","volume":"12","author":"Long","year":"2022","journal-title":"Blood Cancer J"},{"issue":"suppl 1","key":"2025090411220340000_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2023-188547","article-title":"Revised definition of free light chains in serum and light chain monoclonal gammopathy of undetermined significance: results of the Istopmm study [abstract]","volume":"142","author":"Einarsson Long","year":"2023","journal-title":"Blood"},{"issue":"45","key":"2025090411220340000_bib34","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"2025090411220340000_bib35","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s12350-020-02152-x","article-title":"Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation","volume":"28","author":"Cuscaden","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"38","key":"2025090411220340000_bib36","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"issue":"11","key":"2025090411220340000_bib37","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"2","key":"2025090411220340000_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2025090411220340000_bib39","doi-asserted-by":"crossref","first-page":"e033251","DOI":"10.1161\/JAHA.123.033251","article-title":"Coexisting calcific aortic stenosis and transthyretin cardiac amyloidosis: real-world evaluation of clinical characteristics and outcomes","volume":"14","author":"Masri","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"2025090411220340000_bib40","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"2025090411220340000_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2967\/jnmt.123.265568","article-title":"Novel tracers for the imaging of cardiac amyloidosis","volume":"51","author":"Shetty","year":"2023","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"2025090411220340000_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2025090411220340000_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"1","key":"2025090411220340000_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.dadm.2014.11.004","article-title":"A systematic review and meta-analysis of (18)F-labeled amyloid imaging in Alzheimer's disease","volume":"1","author":"Yeo","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"2025090411220340000_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2019.11.037","article-title":"Pittsburgh B compound positron emission tomography in patients with AL cardiac amyloidosis","volume":"75","author":"Lee","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2025090411220340000_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"2025090411220340000_bib47","doi-asserted-by":"crossref","first-page":"693194","DOI":"10.3389\/fcvm.2021.693194","article-title":"Cardiac pilot study of F18-florbetapir in the early evaluation of amyloidosis","volume":"8","author":"Sperry","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"2025090411220340000_bib48","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"issue":"7","key":"2025090411220340000_bib49","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18F-florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2025090411220340000_bib50","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic accuracy of [11C]PIB positron emission tomography for detection of cardiac amyloidosis","volume":"13","author":"Rosengren","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2025090411220340000_bib51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/13506129.2022.2120388","article-title":"Reduction of cardiac AL amyloid deposition after complete response visualised by PiB-PET imaging","volume":"30","author":"Oguchi","year":"2023","journal-title":"Amyloid"},{"issue":"9","key":"2025090411220340000_bib52","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2025090411220340000_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13506129.2018.1552852","article-title":"A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement","volume":"25","author":"Manwani","year":"2018","journal-title":"Amyloid"},{"issue":"1","key":"2025090411220340000_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-018-0425-1","article-title":"18F-florbetaben whole-body PET\/MRI for evaluation of systemic amyloid deposition","volume":"8","author":"Baratto","year":"2018","journal-title":"EJNMMI Res"},{"issue":"9","key":"2025090411220340000_bib55","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","article-title":"Early detection of multiorgan light-chain amyloidosis by whole-body 18F-florbetapir PET\/CT","volume":"60","author":"Ehman","year":"2019","journal-title":"J Nucl Med"},{"issue":"1","key":"2025090411220340000_bib56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"18F-florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"2025090411220340000_bib57","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"2025090411220340000_bib58","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcmg.2024.05.002","article-title":"Prognostic value of left ventricular 18F-florbetapir uptake in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2025090411220340000_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12350-018-1365-x","article-title":"Cardiac amyloidosis imaging with amyloid positron emission tomography: a systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"2025090411220340000_bib60","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.3390\/molecules20057657","article-title":"Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis","volume":"20","author":"Wall","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"2025090411220340000_bib61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11307-021-01681-2","article-title":"First in human evaluation and dosimetry calculations for peptide 124I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET\/CT imaging","volume":"24","author":"Wall","year":"2022","journal-title":"Mol Imaging Biol"},{"issue":"11","key":"2025090411220340000_bib62","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine 124I evuzamitide (124I-p5+14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/10\/1157\/2411059\/blood_bld-2024-026386-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/10\/1157\/2411059\/blood_bld-2024-026386-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:22:42Z","timestamp":1756999362000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/10\/1157\/546193\/Visualizing-amyloidosis-the-role-of-radionuclide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024026386","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,4]]},"published":{"date-parts":[[2025,9,4]]}}}